Gary E Raskob Selected Research

Gary E Raskob Research Topics

Disease

49	Venous Thromboembolism 07/2023 - 12/2003
48	Hemorrhage 07/2023 - 12/2003
17	Neoplasms (Cancer) 01/2023 - 06/2008
16	Pulmonary Embolism 10/2022 - 03/2004
16	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 09/2004
4	Thromboembolism 12/2021 - 09/2007
3	Thrombosis (Thrombus) 01/2023 - 06/2008
3	Embolism (Embolus) 10/2022 - 11/2021
3	Body Weight (Weight, Body) 10/2018 - 10/2013
2	Atrial Fibrillation 07/2023 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 08/2018
2	Bronchiectasis 01/2021 - 01/2019
2	Stroke (Strokes) 01/2020 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 01/2016 - 10/2014
2	Wounds and Injuries (Trauma) 04/2010 - 03/2010
2	Postthrombotic Syndrome 06/2008 - 09/2004
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2023
1	Heart Failure 10/2022
1	Myocardial Infarction 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Frailty 10/2018
1	Renal Insufficiency (Renal Failure) 09/2018
1	Thrombotic Microangiopathies 05/2016
1	Thrombocytopenia (Thrombopenia) 05/2016
1	Pulmonary Hypertension 01/2016
1	Healthcare-Associated Pneumonia 10/2014
1	Infections 10/2014
1	Right Ventricular Dysfunction 10/2013
1	Surgical Wound 12/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2003
1	Diarrhea 07/2003
1	Hemolytic-Uremic Syndrome 07/2003
1	Thrombotic Thrombocytopenic Purpura 07/2003
1	Upper Extremity Deep Vein Thrombosis 02/2002

Drug/Important Bio-Agent (IBA)

20	AnticoagulantsIBA 07/2023 - 02/2002
20	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023 - 01/2009
18	RivaroxabanIBA 10/2022 - 12/2010
12	Warfarin (Coumadin)FDA LinkGeneric 07/2023 - 12/2003
11	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023 - 12/2003
11	apixabanIBA 01/2021 - 08/2009
11	Factor Xa InhibitorsIBA 01/2018 - 08/2009
10	Vitamin K FDA Link 07/2023 - 09/2007
10	edoxabanIBA 12/2021 - 10/2013
8	Heparin (Liquaemin)FDA LinkGeneric 10/2013 - 09/2004
6	fibrin fragment D (D-dimer)IBA 01/2020 - 03/2004
4	CreatinineIBA 10/2022 - 10/2013
4	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 12/2003
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2023 - 01/2015
3	Dabigatran FDA Link 01/2019 - 01/2009
3	idraparinuxIBA 07/2010 - 09/2007
3	Fondaparinux (Arixtra)FDA Link 04/2009 - 12/2003
2	Thrombin FDA Link 07/2023 - 01/2009
2	Factor Xa (Coagulation Factor Xa)IBA 07/2023 - 01/2012
2	ORALIT (ORS)IBA 12/2021 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 12/2021 - 10/2021
2	abelacimabIBA 12/2021 - 11/2021
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2018 - 08/2016
1	Factor XIa (Coagulation Factor XIa)IBA 12/2021
1	milvexianIBA 12/2021
1	osocimabIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Cytochrome P-450 CYP3AIBA 10/2018
1	Quinidine (Chinidin)FDA LinkGeneric 08/2016
1	Verapamil (Calan)FDA LinkGeneric 08/2016
1	PlacebosIBA 08/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 08/2016
1	Quinine (Quinson)FDA Link 05/2016
1	vinyltriethoxysilane (VTES)IBA 01/2016
1	Antisense OligonucleotidesIBA 01/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2013
1	boldenone undecylenate (Equipoise)IBA 01/2013
1	idrabiotaparinuxIBA 01/2012
1	EG 6IBA 12/2003
1	RHO(D) antibody (anti-D)IBA 11/2003
1	thiamine triphosphorate (TTP)IBA 07/2003

Therapy/Procedure

18	Therapeutics 11/2021 - 02/2002
6	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2021 - 01/2009
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
2	Duration of Therapy 08/2018 - 02/2018
2	Catheters 10/2014 - 06/2008
2	Compression Stockings 06/2008 - 09/2004
1	Polypharmacy 01/2018
1	Subcutaneous Injections 07/2010
1	Critical Care (Surgical Intensive Care) 04/2010
1	Replacement Arthroplasty 03/2010
1	Thrombolytic Therapy 09/2004
1	Orthopedic Procedures 12/2003
1	Plasma Exchange 07/2003
1	Stem Cell Transplantation 07/2003